Endotracheal intubation as well as extubation are associated with various cardiovascular and airway
responses leading to increase in heart rate (tachycardia), hypertension (HTN), cardiac arrhythmias,
myocardial ischemia (MI), coughing, agitation, bronchospasm, increased bleeding, raised intracranial tension etc.
Pneumoperitoneum creation in laparoscopic surgeries, leads to adverse changes in various systems of human body including
cardiovascular, respiratory and acid base balance system. Various factors which leads to haemodynamic changes in patient
are release of catecholamine, carbon di-oxide absorption, vasopressin release and position of the patient. NTG generate NO
(Nitric oxide) which causes vasodilatation in vascular smooth muscle leading to decrease in blood pressure. It also relaxes the
respiratory tract smooth muscle and hence it is preferred by anaesthesiologist to prevent laryngospasm. Dexmedetomidine is
an 2-adrenoreceptor agonist used to facilitate the extubation after surgeries. Dexmedetomidine used in the intraoperative
period causes decrease in serum catecholamine levels by 90%, which in turn blunts the haemodynamic response to
laryngoscopy, tracheal intubation, pneumo-peritoneum and extubation. So we did the comparative study between IV
dexmedetomidine and IV NTG on hemodynamic response during extubation in laparoscopic surgeries. To study and compare
the effect of intravenous nitro-glycerine (NTG) with dexmedetomidine in patients undergoing laparoscopic surgery and during
recovery in terms of haemodynamic response during tracheal extubation, airway reexes during tracheal extubation by using
extubation quality score, sedation by using Ramsay Sedation Scale & side effects of drug. 60 patients of ASA grade 1 and 2
undergoing laparoscopic surgery were divided into two groups of thirty each. GROUP D (n=30) will receive Dexmedetomidine
infusion at the rate of 0.75 mics/kg over 10 minutes and GROUP N (n=30) will receive NTG infusion at the rate of 2 mics/kg over
10 minutes .patients were assessed on the basis of ramsay sedation scale , extubation quality scale and vas scale every 1, 3, 5,
10 and 15 minutes. When both the groups were compared it was found out there was statistically signicant difference in
dexmedetomidine group as compared to NTG in terms of decrease in HR , BP, SBP , DBP, MAP , extubation quality score ,
ramsay sedation scale, and VAS scale .there was no overall complication in both groups. In conclusion, the Dexmedetomidine
at a dose of 0.75µg/kg body weight as compared to NTG ( 2 µg/kg body weight )when administered as infusion over 10 minutes,
before tracheal extubation attenuates the airway reexes and hemodynamic responses effectively during emergence from
anaesthesia providing smooth extubation. It provide adequate sedation, maintaining patient's arousability and delay the need
for analgesia in the post-operative period.